Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stock
Albert David Limited (ADL) specializes in manufacturing and trading pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs, both domestically and internationally.
The company is a significant player in the IV fluid manufacturing sector, with production capabilities in both glass and polyethylene containers.
ADL has engaged in several technical collaborations, notably with Morishita Pharmaceuticals for amino acid infusions and Pharma Plan, Germany for syringe and needle manufacturing.
Over the years, ADL has consistently launched new pharmaceutical products across various categories, reflecting its focus on innovation and market adaptation.
ADL is part of the Kothari Group, a prominent industrial house in Kolkata, highlighting a strong backing in capital and strategic direction.
Pharmaceuticals & Biotechnology
Pharmaceuticals
395 Cr
Low Risk
0.0
36.7
—
1.0
921.60
581.30
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
5
Neutral
6
Bullish
3
Bearish
29
Neutral
6
Bullish
11
Bearish
24
Neutral
0
Bullish
8
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Albert David Ltd (ALBERTDAVD) is currently trading at 692.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Albert David Limited (ADL) specializes in manufacturing and trading pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs, both domestically and internationally. The company is a significant player in the IV fluid manufacturing sector, with production capabilities in both glass and polyethylene containers. ADL has engaged in several technical collaborations, notably with Morishita Pharmaceuticals for amino acid infusions and Pharma Plan, Germany for syringe and needle manufacturing. Over the years, ADL has consistently launched new pharmaceutical products across various categories, reflecting its focus on innovation and market adaptation. ADL is part of the Kothari Group, a prominent industrial house in Kolkata, highlighting a strong backing in capital and strategic direction.
Over the past 52 weeks, Albert David Ltd has traded between a low of ₹581.30 and a high of ₹921.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Albert David Ltd has a market capitalization of approximately 395.13. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Albert David Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 395.13 Cr, Albert David Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Albert David Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Albert David Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Board Meeting
Albert David Ltd will hold a Board meeting on 2026-08-06 to consider, approve and take on record unaudited financial results for the quarter ended 30 June 2026; trading window closed until 48 hours after results.
Board Meeting
Albert David Ltd has scheduled a Board meeting on 2026-08-06 to consider, approve and take on record the unaudited financial results for Q1 ended 2026-06-30. Trading window closed from 2026-07-01, reopens 48 hrs after results.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
254.50 | 436 Cr | — | 21.84 | 0.00 | 19.79 | 23.50 | 10.61 | ||
355.35 | 435 Cr | 101.24 | 5.20 | 0.00 | 5.14 | 6.71 | 4.89 | ||
692.00 | 395 Cr | — | 1.01 | 0.72 | -0.38 | 0.75 | -0.29 | ||
82.00 | 362 Cr | 24.57 | 1.06 | 0.00 | 4.41 | 5.15 | — | ||
594.00 | 340 Cr | 31.42 | 4.49 | 0.85 | 14.04 | 19.30 | 10.92 | ||
243.25 | 328 Cr | 34.06 | 1.19 | 0.41 | 3.50 | 4.79 | 2.63 | ||
60.17 | 327 Cr | — | 1.05 | 0.00 | -1.05 | 0.74 | -0.71 | ||
| Median: 7 Co. | — | 254.50 | 362 Cr | 32.74 | 1.19 | 0.00 | 4.41 | 5.15 | 3.76 |
